
Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer
Author(s) -
Yizhi Liu,
Dating Han,
Danrong Shi,
Bo Hong,
Yun Qian,
Zhigang Wu,
Shu-Hao Yao,
Tian Tang,
Ming-Hai Wang,
Xiao Xu,
HangPing Yao
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i11.1216
Subject(s) - medicine , colorectal cancer , pathological , cancer , cancer research , clinical significance , pathology
Programmed death ligand 1 (PD-L1) immunotherapy remains poorly efficacious in colorectal cancer (CRC). The recepteur d'origine nantais (RON) receptor tyrosine kinase plays an important role in regulating tumor immunity.